CRIS Current Research Information System

GATTA, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.954
AS - Asia 1.323
EU - Europa 1.251
AF - Africa 102
Continente sconosciuto - Info sul continente non disponibili 100
SA - Sud America 77
OC - Oceania 6
Totale 4.813
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.905
IT - Italia 413
SG - Singapore 360
CN - Cina 338
VN - Vietnam 294
GB - Regno Unito 243
DE - Germania 139
SE - Svezia 108
HK - Hong Kong 92
FR - Francia 64
IN - India 56
BR - Brasile 54
CH - Svizzera 50
RU - Federazione Russa 47
IE - Irlanda 42
TG - Togo 34
BD - Bangladesh 33
CA - Canada 32
ZA - Sudafrica 31
JP - Giappone 29
UA - Ucraina 26
NL - Olanda 25
JO - Giordania 21
KR - Corea 20
SC - Seychelles 18
ID - Indonesia 17
FI - Finlandia 16
BE - Belgio 14
EE - Estonia 14
BG - Bulgaria 13
CI - Costa d'Avorio 13
TR - Turchia 13
AR - Argentina 11
TH - Thailandia 8
ES - Italia 6
PH - Filippine 6
AT - Austria 5
AU - Australia 5
EC - Ecuador 5
GR - Grecia 5
MX - Messico 5
PK - Pakistan 5
RO - Romania 5
IR - Iran 4
JM - Giamaica 4
AE - Emirati Arabi Uniti 3
HR - Croazia 3
IQ - Iraq 3
LT - Lituania 3
MY - Malesia 3
PL - Polonia 3
PR - Porto Rico 3
SA - Arabia Saudita 3
TW - Taiwan 3
AZ - Azerbaigian 2
CO - Colombia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
PE - Perù 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
BH - Bahrain 1
CD - Congo 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
EU - Europa 1
GH - Ghana 1
HN - Honduras 1
HT - Haiti 1
KE - Kenya 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MQ - Martinica 1
NO - Norvegia 1
NR - Nauru 1
PA - Panama 1
PS - Palestinian Territory 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZM - Zambia 1
Totale 4.714
Salva come PNG Salva come JPEG
Città #
Singapore 267
Ashburn 208
Southend 205
Fairfield 170
Chandler 136
Bologna 110
San Jose 100
Ann Arbor 98
Hong Kong 90
Houston 87
Hanoi 81
Ho Chi Minh City 74
Seattle 66
Wilmington 65
Woodbridge 65
Cambridge 63
Santa Clara 57
Beijing 47
Dallas 46
New York 45
Princeton 44
Dublin 42
Boardman 40
Bern 38
Los Angeles 38
Council Bluffs 37
Hefei 36
Lomé 34
Milan 30
Tokyo 24
Lauterbourg 22
Amman 21
Turin 21
Nanjing 19
Redmond 18
Westminster 18
Berlin 17
Da Nang 16
Bremen 15
Jakarta 15
Johannesburg 15
Brussels 14
Buffalo 14
Guangzhou 14
Padova 14
Abidjan 13
Frankfurt am Main 13
Rome 13
Seoul 13
Sofia 13
Helsinki 12
São Paulo 12
Toronto 12
Bulle 11
Changsha 11
Jacksonville 11
Phoenix 11
Jinan 10
Dearborn 9
Dong Ket 9
London 9
Montreal 9
Redondo Beach 9
Redwood City 9
Brooklyn 8
Haiphong 8
Istanbul 8
Orem 8
Tianjin 8
Chicago 7
Rimini 7
San Diego 7
Shenzhen 7
Des Moines 6
Düsseldorf 6
Genoa 6
Hebei 6
Nanchang 6
Piscataway 6
Saint Petersburg 6
Zhengzhou 6
Jiaxing 5
Paris 5
Shanghai 5
Shenyang 5
Acate 4
Bắc Giang 4
Chengdu 4
Falkenstein 4
Forlì 4
Hải Dương 4
Lappeenranta 4
Ottawa 4
Rovigo 4
San Antonio 4
Shijiazhuang 4
Stockholm 4
Washington 4
Yubileyny 4
Battipaglia 3
Totale 3.100
Salva come PNG Salva come JPEG
Nome #
Rescue, Purification, and Characterization of a Recombinant HSV Expressing a Transgenic Protein 289
oHSV Genome Editing by Means of galK Recombineering 287
Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases 267
Three-dimensional virtual anatomy as a new approach for medical student’s learning 264
Preclinical therapy of disseminated HER-2+ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus. 263
A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors 261
Retargeting strategies for oncolytic herpes simplex viruses 244
Rethinking herpes simplex virus: the way to oncolytic agents. 240
HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses 240
The simultaneous insertion of two ligands in gD for the cultivation of oncolytic HSVs in non-cancer cells and the retargeting to cancer receptors 223
Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells. 221
Insertion of a ligand to HER2 in gB retargets HSV tropism and obviates the need for activation of the other entry glycoproteins 212
Dual Ligand Insertion in gB and gD of Oncolytic Herpes Simplex Viruses for Retargeting to a Producer Vero Cell Line and to Cancer Cells 211
A strategy for cultivation of retargeted oncolytic herpes simplex viruses in non-cancer cells 207
Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha synuclein 187
Replication-competent herpes simplex virus retargeted to HER2 as therapy for high-grade glioma 187
The Engineering of a Novel Ligand in gH Confers to HSV an Expanded Tropism Independent of gD Activation by Its Receptors 182
Efficacy of HER2 retargeted herpes simplex virus as therapy for high-grade glioma in immunocompetent mice. 181
Immunotherapeutic efficacy of retargeted ohsvs designed for propagation in an ad hoc cell line 165
{alpha}V{beta}3-integrin routes herpes simplex virus to an entry pathway dependent on cholesterol-rich lipid rafts and dynamin2. 152
Implication of Cellular Senescence in Osteoarthritis: A Study on Equine Synovial Fluid Mesenchymal Stromal Cells 143
Vascular Mesenchymal Stromal Cells and Cellular Senescence: A Two-Case Study Investigating the Correlation Between an Inflammatory Microenvironment and Abdominal Aortic Aneurysm Development 112
Impact of Photobiomodulation on the Pro-Osteogenic Activity of Dental Pulp Mesenchymal Stem/Stromal Cells 75
Totale 4.813
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.727
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.727
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022389 0 0 57 22 35 21 21 36 10 40 88 59
2022/2023599 63 80 23 71 52 36 20 27 99 23 52 53
2023/2024195 12 29 11 35 9 44 4 11 3 15 3 19
2024/2025581 45 69 41 47 83 42 36 22 9 50 47 90
2025/20261.626 111 137 146 153 152 87 140 44 313 194 75 74
2026/2027116 41 31 44 0 0 0 0 0 0 0 0 0
Totale 4.813